Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 4 | Unknown | PO / MO |
The patient took one or two doses of Vivotif vaccine together with Vitamin gummies at the same time; Case reference number US-BN-2024-002481 is a spontaneous case initially received from a consumer via agency (reference number USBAV24-2347) on 12-Sep-2024 and concerns a female patient of unspecified age. The patient's medical history details was not provided. The patient's concomitant medications included vitamin gummies (brand name unknown). On unspecified dates, the patient took the first, second, third, and fourth dose of Vivotif (batch number: unknown), at a dose of a capsule, orally, for typhoid Immunization. As reported, the patient took one or two Vivotif capsules with vitamin gummies at the same time, because normally the patient took all medications at the same time (explicitly coded as 'product administration error'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. Non-significant follow-up was downloaded from VAERS on 09-May-2025 included new reference number. Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20240912-ab93eb to US-BAVARIAN NORDIC A/S-US-BN-2024-002481, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A female patient of unspecified age took one or two Vivotif capsules for typhoid Immunization with vitamin gummies at the same time, because normally the patient took all medications at the same time, which is considered as product administration error. It was unknown if the patient experienced any adverse event due to Vivotif. Product administration error is considered as listed per company convention. The patient's medical history was not provided, and concomitant medications included vitamin gummies. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A female patient of unspecified age took one or two Vivotif capsules for typhoid Immunization with vitamin gummies at the same time, because normally the patient took all medications at the same time, which is considered as product administration error. It was unknown if the patient experienced any adverse event due to Vivotif. Product administration error is considered as listed per company convention. The patient's medical history was not provided, and concomitant medications included vitamin gummies. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None
VITAMINS NOS